Latest news

South American bioprospecting treaty

January 4, 2009

Chromologica is working on securing a bioprospecting treaty with several key South American countries. The governments of Peru, Ecuador and Bolivia will allow the company's bio-researchers access to their rainforests in return for a share of the profits from any products developed.

Vaccine RV1 launch date announced

December 24, 2008

Rotavirus vaccine RV1 is to launch on June 1, 2009. Developed from rare plant DNA discovered in the Cameroonian jungle, the vaccine will potentially save thousands of children's lives every year.

Step forward in Alzheimer's project

December 10, 2008

Extensive research into the properties of a Peruvian plant used by indigenous tribes as a memory aid is to go ahead as part of Chromologica's work into treatments for Alzheimer's.

Stroke treatment to enter Phase III

December 1, 2008

Phase III trials of neuroprotective agent CHR-513 are to take place among patients recovering from strokes. If successful, CHR-513 could be on the market as soon as 2011.

Takbunuaz expedition halted

November 27, 2008

A research expedition to a Taiwanese Takbunuaz tribal area has been halted due to an outbreak of flu. The tribe has elected to quarantine itself while vaccines and treatments are administered.